Skip to main content

UBS Group AG

Position in IFRX — InflaRx N.V.

CIK 1610520 ZURICH, V8

Position in IFRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$177,256
+$150,615 QoQ
Shares Held
79,133
+165.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 62 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. IFRX ranks #342 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IFRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $177,256 79,133
2026-03-31 $26,641 29,800
2025-12-31 $35,064 34,717
2025-09-30 $30,043 22,421
2025-06-30 $6,395 8,095
2024-12-31 $166,578 67,441
2023-09-30 $1,379 463
2022-12-31 $1,562 504
2022-09-30 $14,153 5,361
2022-03-31 $4,540 2,481
2021-12-31 $21,381 4,492
2021-09-30 $12,988 5,015
2021-06-30 $3,697 1,245
2021-03-31 $25,463 6,529
2020-12-31 $9,788 1,946
2020-09-30 $7,961 1,869
2020-06-30 $6,302 1,373
2020-03-31 $9,110 2,385